TransMedics Group (NASDAQ: TMDX)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of TransMedics Group (NASDAQ: TMDX) through any online brokerage.
The latest price target for TransMedics Group (NASDAQ: TMDX) was reported by Morgan Stanley on Wednesday, June 29, 2022. The analyst firm set a price target for 34.00 expecting TMDX to fall to within 12 months (a possible -2.45% downside). 6 analyst firms have reported ratings in the last year.
The stock price for TransMedics Group (NASDAQ: TMDX) is $34.855 last updated Today at July 5, 2022, 6:50 PM UTC.
There are no upcoming dividends for TransMedics Group.
TransMedics Group’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for TransMedics Group.
TransMedics Group is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.